![](/img/cover-not-exists.png)
714PPhase I study of the oncolytic viral immunotherapy agent canerpaturev (C-REV) with S-1 in patients with stage IV pancreatic cancer
Hijioka, S, Ueno, M, Ioka, T, Hirooka, Y, Ohno, E, Okusaka, T, Maruki, Y, Kobayashi, S, Ashida, R, Yashika, J, Furuse, J, Ikeda, M, Kasuya, H, Tanaka, M, Hashimoto, YVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.041
Date:
October, 2019
File:
PDF, 90 KB
2019